Literature DB >> 17470647

Extended-spectrum beta-lactamases of the CTX-M type now in Switzerland.

Marie-Frédérique Lartigue1, Catherine Zinsius, Aline Wenger, Jacques Bille, Laurent Poirel, Patrice Nordmann.   

Abstract

The epidemiology of clavulanic acid-inhibited extended-spectrum beta-lactamases (ESBLs) was investigated among infection-associated enterobacterial isolates at the University Hospital in Lausanne, Switzerland, from January 2004 to June 2005. Out of 57 nonrepetitive ESBL producers (prevalence rate of 0.7%), 45 produced CTX-M-like ESBLs. CTX-M enzymes were mostly from clonally nonrelated Escherichia coli isolates, from urinary infections and community-acquired infections. Pediatric patients (20 out of 57) accounted for a large number of CTX-M producers. CTX-M-15 was the most frequent CTX-M-type enzyme. The plasmid-located bla(CTX-M) genes were associated with either ISEcp1 or ISCR1 insertion sequences. This study is the first published report of CTX-M-type beta-lactamases in Switzerland.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17470647      PMCID: PMC1932552          DOI: 10.1128/AAC.01614-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

1.  Plasmid-mediated extended-spectrum beta-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1.

Authors:  A Karim; L Poirel; S Nagarajan; P Nordmann
Journal:  FEMS Microbiol Lett       Date:  2001-07-24       Impact factor: 2.742

2.  Diversity of CTX-M beta-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals.

Authors:  Michèle Saladin; Van Thi Bao Cao; Thierry Lambert; Jean-Luc Donay; Jean-Louis Herrmann; Zahia Ould-Hocine; Charlotte Verdet; Françoise Delisle; Alain Philippon; Guillaume Arlet
Journal:  FEMS Microbiol Lett       Date:  2002-04-09       Impact factor: 2.742

3.  Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum beta-lactamase CTX-M-15 and of its structurally related beta-lactamase CTX-M-3.

Authors:  Laurent Poirel; Marek Gniadkowski; Patrice Nordmann
Journal:  J Antimicrob Chemother       Date:  2002-12       Impact factor: 5.790

4.  Socioeconomic determinants of regional differences in outpatient antibiotic consumption: evidence from Switzerland.

Authors:  Massimo Filippini; Giuliano Masiero; Karine Moschetti
Journal:  Health Policy       Date:  2005-11-10       Impact factor: 2.980

5.  Widely distributed and predominant CTX-M extended-spectrum beta-lactamases in Amsterdam, The Netherlands.

Authors:  N al Naiemi; A Bart; M D de Jong; C M Vandenbroucke-Grauls; P J G M Rietra; Y J Debets-Ossenkopp; P C Wever; L Spanjaard; A J Bos; B Duim
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

Review 6.  The CTX-M beta-lactamase pandemic.

Authors:  Rafael Cantón; Teresa M Coque
Journal:  Curr Opin Microbiol       Date:  2006-08-30       Impact factor: 7.934

7.  Identification and broad dissemination of the CTX-M-14 beta-lactamase in different Escherichia coli strains in the northwest area of Spain.

Authors:  German Bou; Monica Cartelle; Maria Tomas; Delia Canle; Francisca Molina; Rita Moure; Jose Maria Eiros; Antonio Guerrero
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

8.  qnrA in CTX-M-producing Escherichia coli isolates from France.

Authors:  Jean-Philippe Lavigne; Hélène Marchandin; Julien Delmas; Nicole Bouziges; Evelyne Lecaillon; Laurent Cavalie; Hélène Jean-Pierre; Richard Bonnet; Albert Sotto
Journal:  Antimicrob Agents Chemother       Date:  2006-09-18       Impact factor: 5.191

9.  Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002.

Authors:  Ellen S Moland; Nancy D Hanson; Jennifer A Black; Ashfaque Hossain; Wonkeun Song; Kenneth S Thomson
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

10.  CTX-M-type extended-spectrum beta-lactamase that hydrolyzes ceftazidime through a single amino acid substitution in the omega loop.

Authors:  L Poirel; T Naas; I Le Thomas; A Karim; E Bingen; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

View more
  27 in total

1.  Plasmid-mediated 16S rRNA methylases among extended-spectrum beta-lactamase-producing Enterobacteriaceae isolates.

Authors:  Béatrice Berçot; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2008-10-06       Impact factor: 5.191

2.  Antimicrobial resistance gene distribution: a socioeconomic and sociocultural perspective.

Authors:  Kayode K Ojo; Amy R Sapkota; Tokunbo B Ojo; Paul S Pottinger
Journal:  GMS Krankenhhyg Interdiszip       Date:  2008-09-03

3.  Prevalence and molecular characterization of extended-spectrum-β-lactamase-producing Enterobacteriaceae in a pediatric patient population.

Authors:  Lakshmi Chandramohan; Paula A Revell
Journal:  Antimicrob Agents Chemother       Date:  2012-06-25       Impact factor: 5.191

4.  Screening and Characterization of Multidrug-Resistant Gram-Negative Bacteria from a Remote African Area, São Tomé and Príncipe.

Authors:  Laurent Poirel; Marta Aires-de-Sousa; Patrick Kudyba; Nicolas Kieffer; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

5.  Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy.

Authors:  S Meier; R Weber; R Zbinden; C Ruef; B Hasse
Journal:  Infection       Date:  2011-06-25       Impact factor: 3.553

6.  High Rate of Association of 16S rRNA Methylases and Carbapenemases in Enterobacteriaceae Recovered from Hospitalized Children in Angola.

Authors:  Laurent Poirel; Juliette Goutines; Marta Aires-de-Sousa; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

7.  Molecular identification of extended-spectrum-β-lactamase genes from Enterobacteriaceae isolated from healthy human carriers in Switzerland.

Authors:  Nadine Geser; Roger Stephan; Bozena M Korczak; Lothar Beutin; Herbert Hächler
Journal:  Antimicrob Agents Chemother       Date:  2011-12-12       Impact factor: 5.191

8.  Characteristics of extended-spectrum β-lactamase- and carbapenemase-producing Enterobacteriaceae Isolates from rivers and lakes in Switzerland.

Authors:  Katrin Zurfluh; Herbert Hächler; Magdalena Nüesch-Inderbinen; Roger Stephan
Journal:  Appl Environ Microbiol       Date:  2013-03-01       Impact factor: 4.792

9.  High Prevalence of Carbapenemase-Producing Enterobacteriaceae among Hospitalized Children in Luanda, Angola.

Authors:  Nicolas Kieffer; Patrice Nordmann; Marta Aires-de-Sousa; Laurent Poirel
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

10.  Molecular epidemiology of extended-spectrum beta-lactamases among Escherichia coli isolates collected in a Swedish hospital and its associated health care facilities from 2001 to 2006.

Authors:  Hong Fang; Ferda Ataker; Göran Hedin; Kathrine Dornbusch
Journal:  J Clin Microbiol       Date:  2007-12-19       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.